BIOMARIN PHARMACEUTICAL INC
#884 COMPANY RANKING
BioMarin Pharmaceutical Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis type 2, a form of Batten disease; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme for adult patients with PKU; and Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis IV Type A, a lysosomal storage disorder. Its clinical and pre-clinical product pipeline includes valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; vosoritide, a peptide therapeutic that is in Phase III clinical trial for the treatment of achondroplasia, a form of disproportionate short stature in humans; and BMN 307, an AAV5 mediated gene therapy to normalize blood phenylalanine concentration levels in patients with phenylketonuria. The company serves specialty pharmacies; and end-users, such as hospitals and foreign government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has collaboration and license agreements with Sarepta Therapeutics and Asubio Pharma Co., Ltd.; and a preclinical collaboration and license agreement with DiNAQOR AG for the development of gene therapies to treat rare genetic cardiomyopathies. The company was founded in 1996 and is headquartered in San Rafael, California.
Since 1997
Claim This Company
#884
Ranking Index(All Ranking)-1%
Grow & Performance(seo & stats)0
Traffic(Website traffic, unique visiotrs & user retention)- Company Ranking
- Stock Price
BIOMARIN PHARMACEUTICAL INC (BMRN)
5D1M6Mmax
EVERGREEN INDEX #884
BIOMARIN PHARMACEUTICAL INC's stories on HackerNoon
Technology evolves every day, impacting our lives more and more. Don’t miss out on the tech of tomorrow via these remarkable technology stories.
These Biotech Execs Made Perfectly Timed Trades in Health Care Stocks
Sun Feb 25 2024 By Pro Publica
Animal Cloning and New Drugs: How Biotech Works
Thu Mar 12 2020 By Yurii Filipchuk
Fine-Tuning ChatGPT for Improved Performance in Bioinformatics
Tue Apr 15 2025 By Text Mining
Crypto’s Secret Sauce
Tue Oct 23 2018 By Mark D’Aria
BIOMARIN PHARMACEUTICAL INC's latest news & mentions
Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.Biomarin Pharmaceutical Inc.’s (BMRN) Stock: A -4.03% Simple Moving Average for the Past 20 Days
newsheater.com
Wed Nov 01 2023
Earnings Outlook For Biomarin Pharmaceutical
benzinga.com
Tue Oct 31 2023
Assessing Biogen's Performance Against Competitors In Biotechnology Industry
benzinga.com
Mon Oct 30 2023
Newport Beach-based CureDuchenne Welcomes New Executive Director, Vice President of Medical Affairs, and Board Members
newportbeachindy.com
Mon Oct 30 2023
Biotech Industry Leader Takes the Helm of WashU Drug Development Accelerator
indiaeducationdiary.in
Sat Oct 28 2023
BioMarin Pharmaceutical Inc.: A Beacon of Hope for Rare Disease Patients
claytoncountyregister.com
Fri Oct 27 2023
The Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical
finance.yahoo.com
Fri Oct 27 2023
Myotonic Dystrophy Treatment Market Poised for 12.3% CAGR Growth by 2033 | Future Market Insights,Inc.
fmiblog.com
Fri Oct 27 2023
Biotech Stock Roundup: BMY's Q3 Results, PTCT Up on Deal, BEAM's Restructuring News
msn.com
Thu Oct 26 2023
BioMarin Pharmaceutical Inc. (BMRN.VI)
finance.yahoo.com
Tue Oct 24 2023
US FDA approves BioMarin’s Voxzogo for children of all ages with achondroplasia
pharmabiz.com
Mon Oct 23 2023
Bernstein upgrades BioMarin to market perform, citing valuation
seekingalpha.com
Mon Oct 23 2023
BIOMARIN PHARMACEUTICAL INC's Related Companies
Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.Colossal Biosciences
colossal.com
#5461 RANK
Founded2021
Worth10B
ACS biotech
acsbiotech.com
#11211 RANK
Founded2013
Startups of The Year 2023 Winners: Europe by Startups of The Year
Microbial Life on Venus Requires a Unique Life Cycle to Overcome Extreme Conditions by Hypothesis
Amplified Sciences
amplifiedsciences.com
#12387 RANK
Founded2016
THE METHOD OF THE AMMOPHILAE. (For these Sand-wasps, cf.) by Jean-Henri Fabre
Falling in Love With Chatbots Is the Next Cybersecurity Nightmare by Alena Belova
biologit
biologit.com
#12873 RANK
Founded2019
Ellogon AI
ellogon.ai
#6403 RANK
Founded2019
Foray bioscience
foraybio.com
#12501 RANK
